Treatment of celiac disease with IgA
US8709413B2 · kind B2 · utility
6Cited by
0References
19Claims
0Family size
Inventor
Key dates
| Filing date | Aug 22, 2011 |
| Grant date | Apr 29, 2014 |
| Priority date | — |
| Expiry date | Aug 22, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG09G2380/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A process is provided for inhibiting symptoms of food allergy or food intolerance in a subject that includes the oral administration to the subject suffering from food allergy or food intolerance an IgA or an IgM. When administered in a therapeutic quantity based on the subject characteristics and the type of IgA or IgM, symptoms of food allergy or food intolerance in that subject are inhibited. Even non-secretory forms of IgA and IgM are effective when administered orally.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.